A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs
Intra-cellular Targets | Cell surface targets | |
---|---|---|
Cellular | TCR T Cells | CAR T Cells (autologous/allogeneic) |
Recombinant | Bispecific TCR-anti-CD3 (e.g. ImmTACs) | Bispecific antibodies (incl. anti-CD3) |
*If Applicable.